Avacopan, a selective C5a receptor antagonist, for anti-neutrophil cytoplasmic antibody-associated vasculitis

  • Harigai, Masayoshi
  • Takada, Hideto
Modern Rheumatology 32(3):p 475-483, May 2022. | DOI: 10.1093/mr/roab104
Copyright © Copyright Oxford University Press 2022.
View full text|Download PDF